SCHEMBL5015153

SCHEMBL5015153

O=C(O)N1CCC(C#Cc2ccccc2)CC1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 5/20 0.50
FFAR1 O14842 3/20 0.45
FFAR4 Q5NUL3 2/20 0.43
PTGES O14684 1/20 0.40
SCN9A Q15858 1/20 0.40
LMNA P02545 2/20 0.40
RAB9A P51151 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
CASP3 P42574 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
MAPK1 P28482 1/20 0.39
ACHE P22303 1/20 0.39
AR P10275 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13118743 0.87 GRM5 (0.48) GRM5FFAR1FFAR4PTGESSCN9A
SCHEMBL1581839 0.87 GRM5 (0.40) GRM5PTGESSCN9ASMN1; SMN2MAPK1
SCHEMBL1581943 0.86 FFAR1 (0.46) GRM5FFAR1FFAR4MEN1MAPT
SCHEMBL1581531 0.84 NPC1 (0.43) GRM5FFAR1FFAR4LMNARAB9A
SCHEMBL1581685 0.84 GRM5 (0.43) GRM5MEN1KMT2A
SCHEMBL21722921 0.80 RAB9A (0.43) FFAR1LMNARAB9AMEN1KMT2A
SCHEMBL1198456 0.80 GPR119 (0.61) KDM4EMEN1KMT2A
SCHEMBL21497617 0.79 SMN1; SMN2 (0.64) RAB9AMEN1NPC1KMT2ASMN1; SMN2
SCHEMBL1581175 0.78 KDM4E (0.39) KDM4EMEN1KMT2A
SCHEMBL2565461 0.78 APP (0.52) GRM5FFAR1FFAR4PTGESLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1984331-A1 PYRROLIDINE DERIVATIVES AS ERK INHIBITORS SCHERING CORPORATION (US) 2008-10-29 EP disclosed
WO-2007097937-A1 PYRROLIDINE DERIVATIVES AS ERK INHIBITORS SCHERING CORPORATION (US) 2007-08-30 WO disclosed